EC Number | Application | Comment | Organism |
---|---|---|---|
3.5.1.88 | medicine | peptide deformylase is a target for the design of novel antibiotics | Mycobacterium tuberculosis |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
3.5.1.88 | structures of several complexes of Mycobacterium tuberculosis peptide deformylase with the inhibitors are determined at 2.0 to 1.4 A | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.88 | (3R)-3-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]-N-hydroxyheptanamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | (3R)-3-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]heptanoic acid | - |
Mycobacterium tuberculosis | |
3.5.1.88 | (3R)-3-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]-N-hydroxyheptanamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | (3R)-3-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]heptanoic acid | - |
Mycobacterium tuberculosis | |
3.5.1.88 | actinonin | - |
Mycobacterium tuberculosis | |
3.5.1.88 | LBK-611 | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-2-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]heptyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-2-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]hexyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-2-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]pentyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-2-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]heptyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-2-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]hexyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-2-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]pentyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-3-[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-3-[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]-2-benzyl-3-oxopropyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-3-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis | |
3.5.1.88 | N-[(2R)-3-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]-2-benzyl-3-oxopropyl]-N-hydroxyformamide | - |
Mycobacterium tuberculosis |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.88 | Ni2+ | - |
Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.88 | additional information | Mycobacterium tuberculosis | catalyzes the removal of the N-formyl group from the N-terminus of newly synthesized proteins | ? | - |
? | |
3.5.1.88 | additional information | Mycobacterium tuberculosis H37Rv | catalyzes the removal of the N-formyl group from the N-terminus of newly synthesized proteins | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.1.88 | Mycobacterium tuberculosis | P9WIJ3 | - |
- |
3.5.1.88 | Mycobacterium tuberculosis H37Rv | P9WIJ3 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.88 | additional information | catalyzes the removal of the N-formyl group from the N-terminus of newly synthesized proteins | Mycobacterium tuberculosis | ? | - |
? | |
3.5.1.88 | additional information | catalyzes the removal of the N-formyl group from the N-terminus of newly synthesized proteins | Mycobacterium tuberculosis H37Rv | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.1.88 | peptide deformylase | - |
Mycobacterium tuberculosis |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.5.1.88 | 0.000008 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-3-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide | |
3.5.1.88 | 0.00001 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-2-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]hexyl]-N-hydroxyformamide | |
3.5.1.88 | 0.000013 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-2-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]heptyl]-N-hydroxyformamide | |
3.5.1.88 | 0.000013 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-2-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]hexyl]-N-hydroxyformamide | |
3.5.1.88 | 0.000015 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-2-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]heptyl]-N-hydroxyformamide | |
3.5.1.88 | 0.000018 | - |
- |
Mycobacterium tuberculosis | (3R)-3-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]-N-hydroxyheptanamide | |
3.5.1.88 | 0.000021 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-3-[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide | |
3.5.1.88 | 0.000024 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-2-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]pentyl]-N-hydroxyformamide | |
3.5.1.88 | 0.000028 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-2-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]pentyl]-N-hydroxyformamide | |
3.5.1.88 | 0.000049 | - |
- |
Mycobacterium tuberculosis | (3R)-3-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]-N-hydroxyheptanamide | |
3.5.1.88 | 0.000068 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-3-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]-2-benzyl-3-oxopropyl]-N-hydroxyformamide | |
3.5.1.88 | 0.000161 | - |
- |
Mycobacterium tuberculosis | N-[(2R)-3-[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]-2-benzyl-3-oxopropyl]-N-hydroxyformamide | |
3.5.1.88 | 0.000202 | - |
- |
Mycobacterium tuberculosis | (3R)-3-[[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]carbonyl]heptanoic acid | |
3.5.1.88 | 0.000803 | - |
- |
Mycobacterium tuberculosis | (3R)-3-[[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl]heptanoic acid |